JOHNSON & JOHNSON |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 155,930 CLP | 0.00% |
|
0.00% | +14.33% |
| 07-02 | J&J: promising results in multiple myeloma | CF |
| 07-02 | Johnson & Johnson Says Interim Analysis of Blood Cancer Therapy Study Show Promise | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 352B | - | - | - | - | ||
| 823B | ||||||
| 641B | ||||||
| 324B | ||||||
| 301B | ||||||
| 241B |
